A new pharmacological approach: The incretin effect First of all, it should be noted that although they are best known to the public by their trade names (Ozempic, Mounjaro), it is the generic names of these drugs (semaglutide and tirzepatide, respectively) that are used in the scientific literature and we will therefore use this nomenclature throughout this article
In: Handbook of experimental pharmacology
These include signs of severe hypoglycaemia such as confusion, difficulty speaking, loss of consciousness, seizures, or inability to swallow safely
Additionally, NASH-related cirrhosis is the fastest-growing cause of acute-on-chronic liver failure (ACLF), with patients experiencing longer hospital stays, increased use of dialysis and long-term care, higher in-hospital mortality rates, and higher median total health care charges [7]